Timmer T, Terpstra P, van den Berg A, Veldhuis P M, Ter Elst A, Voutsinas G, Hulsbeek M M, Draaijers T G, Looman M W, Kok K, Naylor S L, Buys C H
Department of Medical Genetics, University of Groningen, The Netherlands.
Eur J Hum Genet. 1999 May-Jun;7(4):478-86. doi: 10.1038/sj.ejhg.5200334.
In the search for a tumour suppressor gene in the 3p21.3 region we isolated two genes, RBM5 and RBM6. Gene RBM5 maps to the region which is homozygously deleted in the small cell lung cancer cell line GLC20; RBM6 crosses the telomeric breakpoint of this deletion. Sequence comparison revealed that at the amino acid level both genes show 30% identity. They contain two zinc finger motifs, a bipartite nuclear signal and two RNA binding motifs, suggesting that the proteins for which RBM5 and RBM6 are coding have a DNA/RNA binding function and are located in the nucleus. Northern and Southern analysis did not reveal any abnormalities. By SSCP analysis of 16 lung cancer cell lines we found only in RBM5 a single presumably neutral mutation. By RT-PCR we demonstrated the existence of two alternative splice variants of RBM6, one including and one excluding exon 5, in both normal lung tissue and lung cancer cell lines. Exclusion of exon 5 results in a frameshift which would cause a truncated protein of 520 amino acids instead of 1123 amino acids. In normal lung tissue, the relative amount of the shorter transcript was much greater than that in the lung tumour cell lines, which raises the question whether some tumour suppressor function may be attributed to the derived shorter protein.
在寻找位于3p21.3区域的肿瘤抑制基因的过程中,我们分离出了两个基因,即RBM5和RBM6。基因RBM5定位于小细胞肺癌细胞系GLC20中发生纯合缺失的区域;RBM6跨越了该缺失区域的端粒断点。序列比较显示,在氨基酸水平上,这两个基因具有30%的同一性。它们含有两个锌指基序、一个双分型核信号和两个RNA结合基序,这表明RBM5和RBM6所编码的蛋白质具有DNA/RNA结合功能且定位于细胞核中。Northern和Southern分析未发现任何异常。通过对16个肺癌细胞系进行SSCP分析,我们仅在RBM5中发现了一个可能为中性的突变。通过RT-PCR,我们证实在正常肺组织和肺癌细胞系中均存在RBM6的两种可变剪接变体,一种包含外显子5,另一种不包含外显子5。外显子5的缺失导致移码,这将产生一个由520个氨基酸组成的截短蛋白,而不是由1123个氨基酸组成的蛋白。在正常肺组织中,较短转录本的相对含量远高于肺肿瘤细胞系中的相对含量,这就引发了一个问题,即某些肿瘤抑制功能是否可能归因于由此产生的较短蛋白。